Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells
- PMID: 18996127
- PMCID: PMC4690209
- DOI: 10.1016/j.jim.2008.09.025
Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells
Abstract
The rise in influenza-specific neutralizing antibody levels is proceeded by a burst of antigen-specific antibody secreting cells (ASC) or plasmablasts identified in peripheral blood approximately 5-10 days post immunization. Blood antigen-specific ASC may function as an immune marker of vaccine responses in comparison to the pre- and post-neutralizing titers; however, some have questioned whether there is adequate survival of ASC isolated from peripheral blood after freezing, making multi-center vaccine trials difficult. Here, we demonstrate similar frequencies of influenza-specific ASC from fresh and frozen peripheral blood mononuclear cells (PBMC). Influenza Hemagglutinin (HA) H1, H3, and H7-specific ASC IgG ELISpots frequencies were compared from the same fresh and frozen PBMC 7 days after 2006 Trivalent Influenza Vaccine (TIV) in 10 young healthy subjects. H1-, H3-, and H7-specific IgG ASC spots/10(6) from fresh PBMC on day 7 were 229+/-341, 98+/-90, and 6+/-11 respectively. Total IgG ASC spots/million PBMC pre- and 7-day post-vaccination were 290+/-188 (0.029% PBMC) and 1691+/-836 (0.17% PBMC) respectively. There was no difference in the H1 -H3-, and total specific ASC IgG ELISpot frequencies from the fresh versus frozen PBMC on day 7 (p=0.43, 0.28, 0.28 respectively). These results demonstrate feasibility of testing whether antigen-specific ASC from frozen PBMC are an early biomarker of long-term antibody responses in multi-center vaccine trials.
Figures
Similar articles
-
Peak frequencies of circulating human influenza-specific antibody secreting cells correlate with serum antibody response after immunization.Vaccine. 2010 Apr 30;28(20):3582-7. doi: 10.1016/j.vaccine.2010.02.088. Epub 2010 Mar 16. Vaccine. 2010. PMID: 20298818 Free PMC article.
-
Standard trivalent influenza virus protein vaccination does not prime antibody-dependent cellular cytotoxicity in macaques.J Virol. 2013 Dec;87(24):13706-18. doi: 10.1128/JVI.01666-13. Epub 2013 Oct 9. J Virol. 2013. PMID: 24109221 Free PMC article.
-
Influenza A haemagglutinin specific IgG responses in children and adults after seasonal trivalent live attenuated influenza vaccination.Vaccine. 2017 Oct 9;35(42):5666-5673. doi: 10.1016/j.vaccine.2017.08.044. Epub 2017 Sep 9. Vaccine. 2017. PMID: 28899626 Clinical Trial.
-
Clinical trial to evaluate the safety and immunogenicity of a trivalent surface antigen seasonal influenza vaccine produced in mammalian cell culture and administered to young and elderly adults with and without A(H1N1) pre-vaccination.PLoS One. 2013 Aug 16;8(8):e70866. doi: 10.1371/journal.pone.0070866. eCollection 2013. PLoS One. 2013. PMID: 23976960 Free PMC article. Clinical Trial.
-
Recalling the Future: Immunological Memory Toward Unpredictable Influenza Viruses.Front Immunol. 2019 Jul 2;10:1400. doi: 10.3389/fimmu.2019.01400. eCollection 2019. Front Immunol. 2019. PMID: 31312199 Free PMC article. Review.
Cited by
-
Effect of cryopreservation of peripheral blood mononuclear cells (PBMCs) on the variability of an antigen-specific memory B cell ELISpot.Hum Vaccin Immunother. 2014;10(8):2490-6. doi: 10.4161/hv.29318. Hum Vaccin Immunother. 2014. PMID: 25424961 Free PMC article.
-
Production of IgG antibodies to pneumococcal polysaccharides is associated with expansion of ICOS+ circulating memory T follicular-helper cells which is impaired by HIV infection.PLoS One. 2017 May 2;12(5):e0176641. doi: 10.1371/journal.pone.0176641. eCollection 2017. PLoS One. 2017. PMID: 28463977 Free PMC article.
-
Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.Arthritis Rheumatol. 2016 Oct;68(10):2492-502. doi: 10.1002/art.39706. Arthritis Rheumatol. 2016. PMID: 27059145 Free PMC article.
-
Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy.J Immunol. 2011 Jun 1;186(11):6173-81. doi: 10.4049/jimmunol.1100264. Epub 2011 Apr 29. J Immunol. 2011. PMID: 21531891 Free PMC article.
-
Naive B cells in neuromyelitis optica spectrum disorders: impact of steroid use and relapses.Brain Commun. 2020 Nov 16;2(2):fcaa197. doi: 10.1093/braincomms/fcaa197. eCollection 2020. Brain Commun. 2020. PMID: 33305266 Free PMC article.
References
-
- Amanna IJ, Carlson NE, Slifka MK. Duration of humoral immunity to common viral and vaccine antigens. N Engl J Med. 2007;357:1903–15. - PubMed
-
- Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science. 2002;298:2199–202. - PubMed
-
- Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine. 1994;12:993–9. - PubMed
-
- Radbruch A, Muehlinghaus G, Luger EO, Inamine A, Smith KG, Dorner T, Hiepe F. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol. 2006;6:741–50. - PubMed
-
- Sasaki S, Jaimes MC, Holmes TH, Dekker CL, Mahmood K, Kemble GW, Arvin AM, Greenberg HB. Comparison of the influenza virus-specific effector and memory B-cell responses to immunization of children and adults with live attenuated or inactivated influenza virus vaccines. J Virol. 2007;81:215–28. - PMC - PubMed
MeSH terms
Substances
Grants and funding
- R37 AI049660/AI/NIAID NIH HHS/United States
- R01 AI045969/AI/NIAID NIH HHS/United States
- N01 AI50029/AI/NIAID NIH HHS/United States
- U01 AI045969/AI/NIAID NIH HHS/United States
- K23 AI067501/AI/NIAID NIH HHS/United States
- R24 AI054953/AI/NIAID NIH HHS/United States
- L30 AI057621/AI/NIAID NIH HHS/United States
- N01AI50029/AI/NIAID NIH HHS/United States
- U19 AI056390/AI/NIAID NIH HHS/United States
- M01 RR000044/RR/NCRR NIH HHS/United States
- R01 AI084808/AI/NIAID NIH HHS/United States
- N01AI50020/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous